Stay updated on Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.6.3' was added to the site's revision log, while older items including 'Lung cancer', 'related topics:', 'MedlinePlus Genetics', and 'Revision: v3.6.2' were removed.
    Difference
    0.2%
    Check dated 2026-07-05T13:27:26.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Added Lung cancer and related topics with a MedlinePlus Genetics link to the page's information section. The revision tag was updated to v3.6.2, replacing the previous v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-28T08:16:28.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page's MedlinePlus related topics section has had items removed, including Lung cancer and MedlinePlus Genetics, along with the related topics header.
    Difference
    0.1%
    Check dated 2026-06-21T00:23:10.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Recruitment status shows enrollment is closed, and new sections like How to Read a Study Record, Common Questions, How to Join a Study, and related topics have been added to guide users through the study information.
    Difference
    0.5%
    Check dated 2026-06-14T03:10:32.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer now lists Revision: v3.5.5, replacing the previous revision, and several generic links/topics (Lung cancer, related topics, MedlinePlus Genetics) have been removed.
    Difference
    0.2%
    Check dated 2026-06-07T00:20:23.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Added related topics and links for Lung cancer and MedlinePlus Genetics to the page's related information section, enhancing navigation to disease context and genetics resources.
    Difference
    0.1%
    Check dated 2026-05-30T20:43:45.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial page.